Which medicines that are currently being used in England, contain Graphene Oxide or derivatives of Graphene Oxide.

Medicines and Healthcare Products Regulatory Agency Nid oedd gan y wybodaeth y gofynnwyd amdani.

Dear Medicines and Healthcare Products Regulatory Agency,

Which medicines that are currently being used in England, contain Graphene Oxide or derivatives of Graphene Oxide.

And please specify if any of the ingredients of any medicines are not published due to Trade Secrets.

thanks

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 21/936
       
Dear Paul Lewis,
       
RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
        
Thank you for your enquiry which we received on 17th August 2021.
  
I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt. 
 
If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...
        
Kind Regards,

 
MHRA Customer Service Centre
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

you may want to hurry up with this one

as at least two independent labs have found graphene oxide in the covid injections

the crimes against humanity need to stop

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Paul Lewis,

 

Thank you for your email.

 

There are no licensed medicines that contain graphene.

 

Kind regards,

 

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

 

 

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

You have not answered the questions raised

Please confirm that no licensed medicines or medicines under emergency use authorisation in England
contain either Graphene Oxide or derivatives of Graphene Oxide.

And please specify if any of the ingredients of any medicines are not published due to Trade Secrets.

thanks

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Friday, September 10,
2021 10:14:18 AM To: MHRA Customer Services Subject: Re: FOI 21/936 CSC
63280 Freedom of Information request - Which medicines that are currently
being used in England, contain Graphene Oxide or derivatives of Graphene
Oxide. Dear MHRA Customer Services, You have not answered the questions
raised Please confirm that no licensed medicines or medicines under
emergency use authorisation in England contain either Graphene Oxide or
derivatives of Graphene Oxide. And please specify if any of the
ingredients of any medicines are not published due to Trade Secrets.
thanks Paul Lewis -----Original Message----- Dear Paul Lewis, Thank you
for your email. There are no licensed medicines that contain graphene.
Kind regards, MHRA Customer Service Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU -------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://urldefense.proofpoint.com/v2/url...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://urldefense.proofpoint.com/v2/url...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Paul Lewis,

No licensed medicines or those under emergency use in England contain graphene.

All excipients are published.

Kind regards,

MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

please answer the actual question

Please confirm that no licensed medicines or medicines under emergency use authorisation in England
contain either Graphene Oxide or derivatives of Graphene Oxide.

And please specify if any of the ingredients of any medicines are not published due to Trade Secrets.

Yours sincerely,

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Thursday, September 30,
2021 6:34:12 AM To: MHRA Customer Services Subject: RE: FOI 21/936 CSC
63280 Freedom of Information request - Which medicines that are currently
being used in England, contain Graphene Oxide or derivatives of Graphene
Oxide. Dear MHRA Customer Services, please answer the actual question
Please confirm that no licensed medicines or medicines under emergency use
authorisation in England contain either Graphene Oxide or derivatives of
Graphene Oxide. And please specify if any of the ingredients of any
medicines are not published due to Trade Secrets. Yours sincerely, Paul
Lewis -----Original Message----- Dear Paul Lewis, No licensed medicines or
those under emergency use in England contain graphene. All excipients are
published. Kind regards, MHRA Customer Service Centre Medicines and
Healthcare products Regulatory Agency 10 South Colonnade, Canary Wharf,
London E14 4PU
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Paul Lewis,

No licensed medicines or medicines under emergency use authorisation in England contain either graphene oxide or derivatives of graphene oxide.

There are no "trade secret" ingredients which are not published.

Regards,

MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

thanks

Do you obtain independent laboratory reports to confirm the ingredients or do you rely on the drug manufacturer.

Yours sincerely,

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Monday, October 4, 2021
9:36:19 AM To: MHRA Customer Services Subject: RE: FOI 21/936 CSC 63280
Freedom of Information request - Which medicines that are currently being
used in England, contain Graphene Oxide or derivatives of Graphene Oxide.
Dear MHRA Customer Services, thanks Do you obtain independent laboratory
reports to confirm the ingredients or do you rely on the drug
manufacturer. Yours sincerely, Paul Lewis -----Original Message----- Dear
Paul Lewis, No licensed medicines or medicines under emergency use
authorisation in England contain either graphene oxide or derivatives of
graphene oxide. There are no "trade secret" ingredients which are not
published. Regards, MHRA Customer Service Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU -------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Paul Lewis,

All vaccines authorised and deployed in the UK have been subject to rigorous checks by the MHRA, including individual batch testing and site inspections, even where those sites are outside the UK. For further details please see the Public Assessment Reports.
https://www.gov.uk/government/publicatio...
https://www.gov.uk/government/publicatio...
https://www.gov.uk/government/publicatio...
https://www.gov.uk/government/publicatio...

Please note as this information is available in the public domain this has not been treated as a Freedom of Information request.

Kind regards,

MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

please let me have a copy of the independent laboratory reports detailing the analysis of the ingredients of the
Pfizer, Moderna, AstraZeneca, and Johnson & Johnson Covid-19 'vaccines'

thanks

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Wednesday, October 6,
2021 12:22:23 PM To: MHRA Customer Services Subject: Re: CSC 69703 Freedom
of Information request - Which medicines that are currently being used in
England, contain Graphene Oxide or derivatives of Graphene Oxide. Dear
MHRA Customer Services, please let me have a copy of the independent
laboratory reports detailing the analysis of the ingredients of the
Pfizer, Moderna, AstraZeneca, and Johnson & Johnson Covid-19 'vaccines'
thanks Paul Lewis -----Original Message----- Dear Paul Lewis, All vaccines
authorised and deployed in the UK have been subject to rigorous checks by
the MHRA, including individual batch testing and site inspections, even
where those sites are outside the UK. For further details please see the
Public Assessment Reports.
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note as this information is available in the public domain this has
not been treated as a Freedom of Information request. Kind regards, MHRA
Customer Service Centre Medicines and Healthcare products Regulatory
Agency 10 South Colonnade, Canary Wharf, London E14 4PU
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 21/1129

Dear Paul Lewis,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 6th October 2021.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Paul Lewis,

 

Thank you for your email.

 

Regarding your request for the independent laboratory reports detailing
the analysis of the ingredients of the Pfizer, Moderna, AstraZeneca, and
Johnson & Johnson Covid-19 vaccines, MHRA neither confirms nor denies that
it holds information falling within the description specified in your
request. The duty in Section 1(1)(a) of the Freedom of Information (FOI)
Act 2000 does not apply, by virtue of Section 41 (Information provided in
confidence) and Section 43 (Commercial interests) of that Act. This should
not be taken as an indication that the information you requested is or is
not held by the department.

 

Section 41 is an absolute exemption and no consideration of the public
interest is required, except to state that we consider its disclosure to
constitute an actionable breach of confidence.

 

Section 43 is a conditional exemption and a consideration of the public
interest should be made. We have considered the public interest and cannot
see any public interest argument that outweighs the commercial harm in
releasing any documents that can be used by competitors for their
commercial advantage.

 

If you have a query about the information provided, please reply to this
email

 

If you disagree with how we have interpreted the Freedom of Information
Act 2000 in answering your request, you can ask for an internal review.
Please reply to this email, within two months of this reply, specifying
that you would like an Internal Review to be carried out.

 

Due to the ongoing Covid-19 situation, we are not able to accept delivery
of any documents or correspondence by post or courier to any of our
offices

 

Please remember to quote the reference number above in any future
communications.

 

If you were to remain dissatisfied with the outcome of the internal
review, you would have the right to apply directly to the Information
Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless
you have first contacted us to conduct an internal review. The Information
Commissioner can be contacted at:

 

Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

Yours sincerely

 

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

 

 

 

dangos adrannau a ddyfynnir

Dear Medicines and Healthcare Products Regulatory Agency,

Please pass this on to the person who conducts Freedom of Information reviews.

I am writing to request an internal review of Medicines and Healthcare Products Regulatory Agency's handling of my FOI request 'Which medicines that are currently being used in England, contain Graphene Oxide or derivatives of Graphene Oxide.'.

my request has been refused due to commercial interests. The health of the public should be above ANY commercial interest.

A full history of my FOI request and all correspondence is available on the Internet at this address: http://www.whatdotheyknow.com/request/wh...

Yours faithfully,

Paul Lewis

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Friday, November 26,
2021 1:31:34 PM To: MHRA Customer Services Subject: Internal review of
Freedom of Information request - Which medicines that are currently being
used in England, contain Graphene Oxide or derivatives of Graphene Oxide.
Dear Medicines and Healthcare Products Regulatory Agency, Please pass this
on to the person who conducts Freedom of Information reviews. I am writing
to request an internal review of Medicines and Healthcare Products
Regulatory Agency's handling of my FOI request 'Which medicines that are
currently being used in England, contain Graphene Oxide or derivatives of
Graphene Oxide.'. my request has been refused due to commercial interests.
The health of the public should be above ANY commercial interest. A full
history of my FOI request and all correspondence is available on the
Internet at this address:
https://eur01.safelinks.protection.outlo...
Yours faithfully, Paul Lewis
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Internal Review of FOI 21/1129

Dear Mr Paul Lewis,

Thank you for your email.

We confirm that an internal review will be carried out on FOI 21/1129. We normally aim to respond to requests for internal review within 20 working days of receipt. However, due to high volumes of queries we are currently receiving related to COVID-19 please be aware that responses may take longer than usual.  

Kind Regards  

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

dangos adrannau a ddyfynnir

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Internal Review of FOI 21/1129

 

Dear Paul Lewis,

 

Thank you for your patience whilst we conducted our Internal Review of
21/1129. Our conclusion, is to uphold the views issued in our original
response i.e. to confirm that no licensed medicinal products contain
graphene, therefore, in line with the FOI Act we respond on the grounds of
‘data not held’. However, by way of additional reassurances, we would also
like to mention that companies must disclose the active substance/s and
all excipients as is detailed in the Human Medicines Regulations 2012.

 

The below articles may also be of interest to you.

 

[1]Fact Check-COVID-19 vaccines do not contain graphene oxide | Reuters

[2]Pfizer vaccine does not contain graphene oxide (apnews.com)

 

This concludes our internal review.

 

If you remain dissatisfied, you may ask the ICO to make a decision on
whether or not we have interpreted the FOIA correctly in dealing with the
request and subsequent internal review. The ICO’s address is:

The Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

Yours Sincerely,

 

 

 

 

 

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

 

dangos adrannau a ddyfynnir

Dear MHRA Customer Services,

a recent uk independent laboratory report confirms that graphene is in some of the so called covid vaccines

crimes against humanity.

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Paul Lewis
<[FOI #782750 email]> Sent: Monday, March 7, 2022
8:25:06 AM To: MHRA Customer Services Subject: Re: Internal review of
Freedom of Information request FOI 21/1129 - Which medicines that are
currently being used in England, contain Graphene Oxide or derivatives of
Graphene Oxide. Dear MHRA Customer Services, a recent uk independent
laboratory report confirms that graphene is in some of the so called covid
vaccines crimes against humanity. -----Original Message----- Internal
Review of FOI 21/1129 Dear Paul Lewis, Thank you for your patience whilst
we conducted our Internal Review of 21/1129. Our conclusion, is to uphold
the views issued in our original response i.e. to confirm that no licensed
medicinal products contain graphene, therefore, in line with the FOI Act
we respond on the grounds of ‘data not held’. However, by way of
additional reassurances, we would also like to mention that companies must
disclose the active substance/s and all excipients as is detailed in the
Human Medicines Regulations 2012. The below articles may also be of
interest to you. [1]Fact Check-COVID-19 vaccines do not contain graphene
oxide | Reuters [2]Pfizer vaccine does not contain graphene oxide
(apnews.com) This concludes our internal review. If you remain
dissatisfied, you may ask the ICO to make a decision on whether or not we
have interpreted the FOIA correctly in dealing with the request and
subsequent internal review. The ICO’s address is: The Information
Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF
Yours Sincerely, MHRA Customer Service Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU Telephone 0203 080 6000
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #782750 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

dangos adrannau a ddyfynnir